Greenwood Capital Associates LLC Boosts Stock Holdings in Danaher Co. (NYSE:DHR)

Greenwood Capital Associates LLC lifted its holdings in Danaher Co. (NYSE:DHR) by 19.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,526 shares of the conglomerate’s stock after buying an additional 5,559 shares during the period. Danaher makes up 1.2% of Greenwood Capital Associates LLC’s holdings, making the stock its 19th biggest position. Greenwood Capital Associates LLC’s holdings in Danaher were worth $9,321,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of DHR. Norden Group LLC acquired a new position in Danaher in the first quarter valued at about $276,000. Mutual Advisors LLC lifted its holdings in Danaher by 0.8% during the 1st quarter. Mutual Advisors LLC now owns 6,170 shares of the conglomerate’s stock worth $1,541,000 after buying an additional 47 shares during the last quarter. Callan Capital LLC purchased a new position in shares of Danaher in the 1st quarter valued at $252,000. Avidian Wealth Solutions LLC increased its position in Danaher by 64.6% during the first quarter. Avidian Wealth Solutions LLC now owns 2,565 shares of the conglomerate’s stock worth $640,000 after buying an additional 1,007 shares during the period. Finally, Catalina Capital Group LLC purchased a new stake in shares of Danaher in the first quarter valued at about $642,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Stifel Nicolaus raised their price objective on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Royal Bank of Canada lowered their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. The Goldman Sachs Group raised their price target on shares of Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a report on Thursday, October 31st. Finally, Robert W. Baird cut their target price on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $287.16.

Insider Activity

In related news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 10.90% of the stock is owned by insiders.

Danaher Price Performance

Shares of DHR opened at $247.18 on Tuesday. Danaher Co. has a one year low of $192.35 and a one year high of $281.70. The stock’s fifty day moving average is $266.53 and its 200-day moving average is $260.74. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The firm has a market capitalization of $178.53 billion, a price-to-earnings ratio of 47.17, a price-to-earnings-growth ratio of 4.55 and a beta of 0.85.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the firm earned $2.02 EPS. Equities analysts anticipate that Danaher Co. will post 7.51 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s payout ratio is currently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.